Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2

por Heydari, Amir Hossein, Fathi, Mojtaba, Heydari, Sophia, Heidari, Mohammad Esmaeil
Publicado 2022

Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

por Shahidi, Shabnam, Rostamizadeh, Kobra, Fathi, Mojtaba, Nedaei, Keivan, Ramazani, Ali
Publicado 2022

The assessment of metabolite alteration induced by –OH functionalized multi-walled carbon nanotubes in mice using NMR-based metabonomics

por Baghdadchi, Yasamin, Khoshkam, Maryam, Fathi, Mojtaba, Jalilvand, Ahmad, Fooladsaz, Koorosh, Ramazani, Ali
Publicado 2018

Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study

por Shahidi, Shabnam, Hejazi, Jalal, Moghimi, Minoosh, Borji, Soheila, Zabihian, Saeed, Fathi, Mojtaba
Publicado 2020

Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma

por MAJIDI, Ziba, DJALALI, Mahmoud, JAVANBAKHT, Mohammad Hasan, FATHI, Mojtaba, ZAREI, Mahnaz, FOLADSAZ, Koorosh
Publicado 2017

Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycys...

por Kordestani, Fahimeh, Mazloomi, Sahar, Mortazavi, Yousef, Mazloomzadeh, Saeideh, Fathi, Mojtaba, Rahmanpour, Haleh, Nazarian, Abolfazl
Publicado 2018

Study rationale and design of a study of EMPAgliflozin’s effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial

por Gohari, Sepehr, Reshadmanesh, Tara, Khodabandehloo, Hadi, Fathi, Mojtaba, Ahangar, Hassan, Arsang-Jang, Shahram, Ismail-Beigi, Faramarz, Ghanbari, Samin, Dadashi, Mohsen, Muhammadi, Muhammad Javad, Gohari, Sheida, Ghaffari, Saeid
Publicado 2021

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

por Gohari, Sepehr, Reshadmanesh, Tara, Khodabandehloo, Hadi, Karbalaee-Hasani, Amir, Ahangar, Hassan, Arsang-Jang, Shahram, Ismail-Beigi, Faramarz, Dadashi, Mohsen, Ghanbari, Samin, Taheri, Homa, Fathi, Mojtaba, Muhammadi, Muhammad Javad, Mahmoodian, Reyhaneh, Asgari, Atieh, Tayaranian, Mohammadreza, Moharrami, Mehdi, Mahjani, Mahsa, Ghobadian, Bijan, Chiti, Hossein, Gohari, Sheida
Publicado 2022